Metformin Ameliorates Testicular Damage in Male Mice with Streptozotocin-Induced Type 1 Diabetes through the PK2/PKR Pathway

Liu, Yuning; Yang, Zhen; Kong, Dongbo; Zhang, Youzhi; Yu, Wei; Zha, Wenliang

doi:https://doi.org/10.1155/2019/5681701

Oxidative Medicine and Cellular Longevity

On this page

Abstract Introduction Materials and Methods Results Discussion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Special Issue

Relevance of Fatty Acid Profile, Nutraceutical Intervention, and Oxidative Stress in Spermatogenesis

View this Special Issue

Research Article | Open Access

Volume 2019 | Article ID 5681701 | https://doi.org/10.1155/2019/5681701

Metformin Ameliorates Testicular Damage in Male Mice with Streptozotocin-Induced Type 1 Diabetes through the PK2/PKR Pathway

Yuning Liu,¹Zhen Yang,²Dongbo Kong,³Youzhi Zhang,²Wei Yu,²and Wenliang Zha^1,4,5

Guest Editor: Giulia Collodel

Received01 Jul 2019

Revised18 Oct 2019

Accepted25 Oct 2019

Published28 Nov 2019

Abstract

Approximately 90% of male diabetes mellitus patients have varying degrees of testicular dysfunction. The molecular mechanism underlying diabetes-induced testicular damage has not been thoroughly elucidated. In this research, we sought to determine the influence of metformin (Met) on diabetes-induced testicular injury and the mechanism involved with a focus on testicular dysfunction, apoptosis, autophagy, and prokineticin 2 (PK2) signalling. In our study, C57BL/6J mice were randomly divided into the normal control group, the diabetes group, and the Met-treated group. Streptozotocin (50 mg·kg^-1·d^-1) was injected intraperitoneally into the mice for 5 days in a row to induce type 1 diabetes, which was diagnosed by a blood glucose after 7 days. The experimental animals were orally administered Met (250 mg·kg^-1·d^-1) for 16 weeks. Properties of testicular function, including sperm motility and the total concentration of epididymal sperm, were assessed. Changes in testicular structure, such as the blood-testis barrier, histological pathology, and organelles, were observed. The levels of apoptosis and expression of related proteins, such as Bax and Bcl-2, were measured. Moreover, autophagy-related proteins, including Beclin-1, p62, and LC3B, as well as the PK2/PKR pathway, which consists of PK2, PKR1, PKR2, AKT, and GSK3β, were analysed. Upon the induction of diabetes, reproductive capacity was significantly impaired and a disordered arrangement of testicular seminiferous tubules and destroyed organelles in spermatogenic cells was observed. Met administration preserved testicular function and structure. In addition, in mice with diabetes, the levels of PK2, PKR2, p-Akt, and p-GSK3β were significantly decreased at different times, while that of PKR1 was markedly increased, and these changes were normalized by Met. Furthermore, diabetic mice showed increased apoptosis and decreased autophagy in the testes, the effects of which were nullified by Met. These results suggest that Met rescues diabetes-induced testicular damage by attenuating apoptosis and inducing autophagy. This effect is likely mediated by the PK2/PKR/AKT/GSK3β signalling pathway.

1. Introduction

Diabetes mellitus is a disorder of glucose metabolism caused by an absolute or relative insufficiency of insulin secretion. According to a prediction by the International Diabetes Federation [1], the number of diabetic patients will increase to 693 million in 2045, accounting for approximately 10% of the global population. Recently, researchers have elucidated that testicular dysfunction occurs in a startling number of diabetes cases and that testicular dysfunction has become a prevalent complication of diabetes. Approximately 94.4% of diabetes cases are associated with hypotestosteronaemia, which can lead to diabetic erectile dysfunction [2], and the incidence of sexual and reproductive dysfunction in diabetic patients is 5-10 times higher than that in nondiabetic patients [3, 4]. The major pathological manifestations of diabetes-induced testicular dysfunction include low testosterone levels and compromised reproductive function, which may be attributed to apoptosis and autophagy and may engender hypogonadism. Nevertheless, the precise molecular mechanism by which testicular dysfunction is caused by diabetes remains unclear, and no specific medicines are available for treatment.

Currently, numerous medicines are available for diabetes mellitus, and metformin (Met) is an effective hypoglycaemic drug that can effectively control blood glucose by reducing the absorption of sugar in the intestinal tract, enhancing the intracellular transport of glucose, and inhibiting the production of glycogen in the liver. During its more than 60 years of clinical application, Met has been used not only to control blood glucose levels in patients with diabetes but also to prevent diabetes complications. It has a curative effect on diabetic cardiomyopathy [5] and diabetic retinopathy [6]. Although Met has some effect on other complications caused by diabetes mellitus, it has not been reported for the treatment of testicular dysfunction and the mechanisms of Met in testicular tissue remain unexplored.

Prokineticin 2 (PK2), also called Bombina variegata 8 (Bv8), is a secreted low-molecular-weight protein extracted from the skin secretions of toads [7]. Previous studies have demonstrated that PK2 plays a role in a variety of biological processes, including nerve growth, angiogenesis, the immune response, and inflammation [8–10]. In addition, there is increasing evidence that PK2 plays a role in regulating gonadotropin-releasing hormone (GnRH) for gonadal development, as knockout of the PK2 gene was delayed and deformed in the testes of male mice, leading to spermatogenesis deficiency [8, 11, 12]. Prokineticin receptors (PKRs) are specific G protein-coupled receptors (GPCRs) that comprise two functional complexes, namely, PKR1 and PKR2, which are responsible for the biological effects induced by PK2 in effector cells. Previous studies have shown that PKR2 is more important in the regulation of testicular growth than PKR1 [13]. Although PK2/PKRs play an indispensable role in the reproductive system, there are no reports about their role and mechanism in reproductive injury caused by diabetes mellitus. Accordingly, this study attempted to evaluate the role of Met in diabetes-induced testicular damage, reproductive dysfunction, apoptosis, autophagy, and the PK2/PKR pathway.

2. Materials and Methods

2.1. Experimental Animals

SPF C57BL/6J male mice (18-22 g, 5-6 weeks) were obtained from the Hubei Laboratory Animal Research Center and housed at a temperature of and a moisture content of 40% under a 12 h light/dark cycle. All experimental subjects were treated according to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85–23, revised 1996). All experimental procedures were approved by the Institutional Animal Care and Use Committee of Hubei University of Science and Technology.

2.2. Induction of Experimental Diabetes

A week after adaptive feeding, mice were randomly divided into 2 groups: the control group () and the diabetes group (DM, ). The DM mice were intraperitoneally injected with streptozotocin (STZ, 50 mg·kg^-1·d^-1 in 0.1 mol/L citric acid buffer, pH 4.5) for 5 days in a row [14]. The mice in the control group were injected with an equal amount of citric acid-sodium citrate buffer solution. Random blood glucose was monitored within seven days after STZ injection; the experimental animals with a blood glucose were diagnosed as diabetic, and their blood glucose was monitored weekly [14]. At appropriate time points (2 months, 3 months, 4 months, and 5 months) after the diagnosis of diabetes, the mice were euthanized under anaesthesia, and the testes were quickly removed and stored in Bouin’s fixative fluid for histomorphological examination. The other samples were stored at -80°C for other experiments. The epididymis was collected to determine reproductive function.

2.3. Treatment with Met

Mice were randomly divided into the normal control group (), the DM group (), and the Met treatment group (DM+Met, ). The diabetes model was established according to a previously described method. In the Met treatment group, mice that were diagnosed with diabetes after STZ injection were orally administered Met hydrochloride solution (250 mg·kg^-1·d^-1) in potable water for 4 months. Mice in the other groups were administered an equal volume of water.

2.4. Biotin Tracer Studies

The skin and fascia of anaesthetized mice were incised to expose the testicular tissue. A total of 50 μL of EZ-link Sulfo-NHS-LC-Biotin (50 mg/mL) was injected under the tunica albuginea using a microinjection needle. Thirty minutes after the skin was sutured, the mice were sacrificed, and their testicles were removed and fixed in a fixative solution. The tissue was embedded in paraffin overnight and sectioned. The tissues were dewaxed in xylene and hydrated in graded ethanol solutions. Antigen retrieval was performed by incubating the sections in 5% skim milk in PBS containing 0.01% Triton X-100 for 15 min. An Alexa Fluor 568-conjugated streptavidin solution was diluted with PBS at a 1 : 200 ratio and added to the sections. The sections were incubated at 37°C for 2 h in a dark room and then washed 3 times with PBS. The sections were incubated with DAPI-containing antifluorescence quenching tablets and observed under a fluorescence microscope.

2.5. Measurement of Reproductive Capacity

The cauda epididymes of the mice were placed in physiological saline at 37°C and homogenized. The numbers of active and inactive sperm in 5 visual fields were counted, and the sperm activity rate () was calculated. The sperm suspension was placed in physiological saline at 37°C and dried on a cell counting plate after blending. The concentration of sperm in the five central squares was counted, and the average was multiplied by 10⁹ to obtain the number of sperm per litre of semen, as previously described [15].

2.6. Histopathological Examination

Testicular tissue was soaked in Bouin’s fixative solution for 12 h, embedded in paraffin, and sectioned into 4 μm thick slices. After HE staining, changes in the tissue structure were observed under a light microscope. The testicular tissue was immobilized with an electron microscopy fixative and embedded with an acetone-812 embedding agent. The organelle structure of the testicular tissue was observed by transmission electron microscopy.

2.7. Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick End-Labelling (TUNEL) Assay

A TUNEL assay was performed according to the instructions of the TUNEL kit (Roche Applied Science, USA). Paraffin sections were dewaxed in xylene, rehydrated in a 100%~70% ethanol gradient, and sequentially incubated in 10 μg/mL proteinase K at 37°C for 30 min for antigen retrieval, in 1% Triton X-100 at room temperature for 20 min, in TDT-enzyme and fluorescein-labelled dUTP in proportion at 37°C for 2 h, in 10% serum for 30 min at room temperature, and, finally, in a 10% hydrogen peroxide-methanol solution for 15 min. After 30 min of incubation with converter-POD (HRP-labelled fluorescein antibody), TUNEL-positive cells (green under a microscope) were randomly observed under a fluorescence microscope (Leica, USA). The sections were washed three times with PBS after each step.

2.8. Immunohistochemical Determination of Protein Expression

The samples were incubated with polyclonal primary antibodies at 4°C for 12 h, washed three times with PBS, and then incubated with a biotinylated horse antimouse immunoglobulin (IgG) solution for 1 h. The samples were rinsed with PBS three more times and incubated with freshly prepared 3,3-diaminobenzidine (DAB) solution for colour development. Finally, the sections were sealed with neutral resin and observed under an optical microscope.

2.9. Real-Time Reverse Transcription Polymerase Chain Reaction (RT-qPCR)

TRIzol reagent was used to extract total RNA from the testicular tissues, and 1 μL of RNA from each sample was reverse transcribed into cDNA with the following PCR programme: 95°C for 10 min followed by 40 cycles of 95°C for 15 s and annealing at 60°C for 60 s. After the reaction was completed, the reaction product was separated by agarose gel electrophoresis, and the results were analysed by the ΔΔCT method. Table 1 provides the nucleotide sequences of the primers used in this research.

2.10. Western Blot Analysis

The testicular tissues were weighed, and approximately 50 mg of tissue was added to RIPA buffer (Cell Signaling Technology, USA) that included protease inhibitors and phosphatase inhibitors. The protein concentration was determined by the BCA protein assay (Beyotime, China). Equivalent amounts of protein were loaded onto gels and separated by SDS-PAGE. Then, the following antibodies were used for Western blotting: Beclin-1, LC3B, protein kinase B (AKT), phosphor-AKT, glycogen synthase kinase-3beta (GSK3β), phosphor-GSK3β, Bax, Bcl-2 (1 : 1000, Cell Signaling Technology, USA), p62 (1 : 500, Wanleibio, CN), PK2 (1 : 1000, Abcam, USA), and PKR1 and PKR2 (1 : 2000, Santa Cruz Biotechnology, USA). The samples were incubated with the appropriate secondary antibodies for 1 h at room temperature. The blots were analysed with an ECL kit (Meilunbio, CN).

2.11. Statistical Analysis

The data are presented as the of replicated experiments. Analysis was performed by one-way analysis of variance (ANOVA). Differences with values < 0.05 were considered statistically significant.

3. Results

3.1. General State and Reproductive Potential of Mice over Time

The diabetic mice showed the typical symptoms of diabetes, specifically polydipsia, polyuria, polyphagia, and weight loss. As demonstrated in Table 2, compared with the control group, the diabetic mice had dull, rough, and disorderly hair. In the DM group, body weight was significantly reduced, and a hyperglycaemic status was maintained for a long time (Table 2). In terms of reproductive function, although the total sperm count in the testes of mice in the early stage of diabetes was low compared to that in testes of mice in the normal control group, it was still at a sufficient level to maintain vitality. As the disease progressed, the reproductive capacity of the diabetic mice gradually decreased, and the sperm motility and total sperm count also significantly decreased continuously (Table 2) ( vs. the DM group).

3.2. Diabetes Destroys Normal Testicular Physiological Structure in Mice

The physiological changes in the mice are shown in Figure 1. In the control group, spermatogenic cells at all levels of the spermatogenic epithelium were arranged in an orderly manner, as most of the spermatogenic epithelia had 6-7 layers, and numerous spermatozoa were found in the lumen of the seminiferous tubule. In contrast, the atrophy of and damage to the seminiferous tubules in the testes of diabetic mice resulted in a marked decrease in the number of cell layers in the seminiferous epithelia, with most having 3-4 or fewer layers, and spermatogenesis was significantly reduced in the seminiferous tubules when spermatogenic cells were lost. As the disease progressed, the damage gradually worsened. Within five months, the basic morphology of the testicular seminiferous tubules of the diabetic mice was completely destroyed and normal reproductive function was completely lost.

3.3. Expression of PK2/PKRs in the Testicular Tissue of Diabetic Mice

In previous reports, PK2/PKR2 were found to be important regulatory proteins for the normal physiological function of testicular tissue in mice. Therefore, we speculated that the PK2/PKR signalling pathway affects diabetic mice. As shown in Figure 2, the expression of PK2 and PKR2 was downregulated in diabetic mice compared with control mice. PKR1 levels were downregulated at 2 and 3 months and upregulated at 4 and 5 months in diabetic mice (Figure 2). AKT/GSK3β is the downstream target of PK2/PKRs. In our study, when the PK2/PKR2 protein expression was inhibited, AKT/GSK3β was also expressed at lower levels (Figure 3).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

Figure 2

Testicular expression of the PK2/PKR proteins in the diabetic mouse growth process. (a) Typical protein expression of PK2, PKR1, and PKR2 at 2 months. (b) Typical protein expression of PK2, PKR1, and PKR2 at 3 months. (c) Typical protein expression of PK2, PKR1, and PKR2 at 4 months. (d) Typical protein expression of PK2, PKR1, and PKR2 at 5 months. (e) Quantification of PK2 protein expression at different time points. (f) Quantification of PKR1 protein expression at different time points. (g) Quantification of PKR2 protein expression at different time points. per group. The values are expressed as the . vs. the control group.

(a)

(b)

(c)

(d)

(e)

(f)

Figure 3

Testicular expression of the AKT/GSK3β proteins during the diabetic mouse growth process. (a) Typical protein expression of p-AKT, AKT, p-GSK3β, and GSK3β at 2 months. (b) Typical protein expression of p-AKT, AKT, p-GSK3β, and GSK3β at 3 months. (c) Typical protein expression of p-AKT, AKT, p-GSK3β, and GSK3β at 4 months. (d) Typical protein expression of p-AKT, AKT, p-GSK3β, and GSK3β at 5 months. (e) Quantification of p-AKT/AKT expression at different time points. (f) Quantification of p-GSK3β/GSK3β expression at different time points. per group. The values are presented as the . vs. the control group.

3.4. Expression of AKT/GSK3β in the Testicular Tissues of Diabetic Mice

It is known that the AKT/GSK3β pathway is associated with glycogen synthesis, cell growth, and survival. To further elucidate the potential mechanism underlying diabetes-induced testicular damage, we determined the effects of the AKT/GSK3β signalling pathway on testicular damage. As shown in Figure 3, a significant decrease in the phosphorylation of AKT and GSK3β was found in testis tissue of the DM group compared with the control group (Figure 3).

3.5. Met Improves the General State and Reproductive Capacity of Diabetic Mice

To improve the quality of life and reproductive ability of diabetic mice, we treated diabetic mice with Met for four months. After treatment, the hair of the diabetic mice gradually regained its lustre, the body weights of the mice increased, and the blood glucose levels were also well controlled (Table 3). Furthermore, the sperm vitalities and sperm numbers of the diabetic mice were increased significantly, which enhanced their reproductive potential (Table 3). Compared with the DM mice, the mice treated with Met had better reproductive potential. There were significant differences between the two groups ().

3.6. Met Improves Histomorphological Damage to Testicular Tissue in Diabetic Mice

Similarly, in mice treated with Met, the morphology of the seminiferous tubules in the testes was similar to that in the control group. In the Met treatment group, the damage to the spermatogenic epithelium was significantly alleviated, the number of spermatogenic cell layers was noticeably increased, the cell arrangement was neat, and spermatogenesis was observed (Figure 4(c)). In the biotin tracer study, EZ-link Sulfo-NHS-LC-Biotin was distributed outside of the seminiferous tubules in the control group, but in the diabetic mice, biotin crossed the Sertoli cell gap. Met was able to repair the blood-testis barrier and prevent this damage (Figure 4(b)).

Figure 4

Histomorphological damage in diabetic mice. (a, b) Met prevented biotin from entering the seminiferous tubules. The white arrow indicates biotin between the tubules, and the white triangle indicates biotin in the seminiferous tubules. (a) ; (b) ; ; . (c) Met reversed the morphology of testicular tissue in mice, as determined by HE staining. The black arrowhead shows the spermatogenic cell layers, and the black triangle shows spermatogenesis. ; ; . (d) Met restored the organelle damage in testicular cells, and the red arrow indicates vacuolar degeneration or disintegration in the cytoplasm.

Transmission electron microscopy elucidated that the spermatogenic cells were orderly arranged at all levels of testicular tissue in the control group (Figure 4(d), I). In the DM group, the spermatogenic cells exhibited a disordered arrangement, and vacuolar degeneration or disintegration in the cytoplasm, unclear nucleoli in the nucleus, obvious mitochondrial oedema, massive chromatin aggregation, and widespread breakdown of intercellular bridges were observed (Figure 4(d), II). However, Met treatment normalized the alterations in the mitochondria, which exhibited slight oedema, and chromatin still accumulated (Figure 4(d), III).

3.7. Met Prevents Diabetes Mellitus-Induced Testicular Apoptosis

A TUNEL assay kit was used to detect the number of TUNEL-positive cells. The number of apoptotic cells was elevated in DM mice compared to control mice. Compared with untreated diabetic mice, diabetic mice treated with Met exhibited significantly inhibited diabetes mellitus-induced testicular apoptosis (Figure 5(a)).

Figure 5

Met reduced diabetes mellitus-induced apoptosis in the testes. (a) A typical image of apoptotic cells stained by TUNEL (; ). (b) Typical immunohistochemical staining of Bax (; ). (c) Typical immunohistochemical staining of Bcl-2 (; ). (d) Typical immunohistochemical staining of PCNA (; ). (e) Quantification of Bax mRNA expression. (f) Quantification of Bcl-2 mRNA expression. (g) Quantification of PCNA mRNA expression. (h) A typical image of Bax and Bcl-2 proteins. (i) Quantification of Bax expression. (j) Quantification of Bcl-2 expression. (k) Quantification of the ratio of Bax/Bcl-2 expression. per group. The values are presented as the . vs. the control group; ^# vs. the DM group.

It is well known that Bax and Bcl-2 are regulatory markers of apoptosis. Proliferating cell nuclear antigen (PCNA) is a sliding clamp for the DNA polymerase complex. In addition to having roles in DNA repair and DNA methylation, PCNA has been implicated in apoptosis. As demonstrated in Figure 5, the expression of Bcl-2 and PCNA was decreased, but Bax expression was increased in the testes of the DM group. Met treatment markedly reduced the ratio of Bax/Bcl-2 and increased PCNA expression in diabetic mice (Figure 5).

3.8. Met Activates Autophagy in Testicular Cells in Diabetic Mice

To evaluate the effect of autophagy in testicular injury in diabetes mellitus, we selected the autophagy-related proteins Beclin-1, p62, and light chain 3B (LC3B) to observe changes in autophagy levels in diabetic mice after Met treatment. The data showed that Met effectively activated autophagy in the testicular tissue of mice (Figure 6).

(a)

(b)

(c)

(d)

3.9. Met Activates the PK2/PKR2 Pathway in Mouse Testes

In the above experiments, we proved that PK2/PKRs play an important role in the series of changes that occur during diabetic testicular injury. To evaluate the significance of Met, we analysed the levels of PK2/PKRs in testicular tissues by RT-qPCR, immunohistochemistry, and Western blotting. In contrast to those in the control group, the levels of PK2 and PKR2 were significantly decreased and the levels of PKR1 were increased in the testicular tissues of diabetic mice. Met supplementation significantly reversed these changes (Figure 7).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 7

Met restores the protein expression of PK2/PKRs. (a) Typical immunohistochemical staining of PKRs (; ). (b) Typical expression of PK2 and PKRs. (c) Quantitative analysis of PK2 expression. (d) Quantitative analysis of PKR1 mRNA expression. (e) Quantitative analysis of PKR2 mRNA expression. (f) Quantification of PK2 protein expression. (g) Quantification of PKR1 protein expression. (h) Quantification of PKR2 protein expression. per group. The values are presented as the . vs. the control group; ^# vs. the DM group.

3.10. Met Activates the AKT/GSK3β Signalling Pathway

Akt is a crucial downstream element of the PK2/PKR2 pathway, and the rapamycin receptor in mammals is a key regulator of autophagy under the mediation of AKT. Diabetes significantly decreased the phosphorylation of both AKT and GSK3β in the testis, a change that was reversed by Met (Figure 8).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 8

Met activates AKT/GSK3β protein expression. (a) Typical protein expression of p-AKT and AKT. (b) Typical protein expression of p-GSK3β and GSK3β proteins. (c) Quantification of AKT protein expression. (d) Quantification of p-AKT protein expression. (e) Quantification of p-AKT/AKT protein expression. (f) Quantification of GSK3β protein expression. (g) Quantification of p-GSK3β protein expression. (h) Quantification of p-GSK3β/GSK3β protein expression. per group. The values are presented as the . vs. the control group; ^# vs. the DM group.

4. Discussion

The findings of our study indicate that the PK2/PKR pathway plays an irreplaceable role in diabetic testicular injury and that Met protects against STZ-induced testicular impairment, apoptosis, and autophagy by regulating PK2/PKRs and restores the phosphorylation of the AKT/GSK3β signalling pathway in the testes. Apoptosis and autophagy are caused by glucose toxicity-induced testicular injury in patients with diabetes [15, 16]. While the clinical management of testicular injury remains challenging, our study suggests that Met can act as a treatment for testicular complications in diabetes. Our data demonstrate a likely role of PK2/PKRs in the beneficial effects of Met on diabetes-induced testicular injury.

It is well known that diabetes plays a crucial role in the pathology of testicular dysfunction by leading to the atrophy of the seminiferous tubules and damage to spermatogenetic cells, which are regarded as morphological indices of spermatogenesis dysfunction [17]. We found that diabetic mice exhibited noticeable morphological alterations in their testes, including damage to the structure of the seminiferous tubules and the blood-testis barrier, and a reduced sperm function. Upon treatment with Met, these changes were reversed in our study.

Similar to other GPCRs, the binding of PK2 and PKRs is regulated by local effects and/or endocrine hormones and is coupled with G proteins to mediate multiple biological actions [18]. Accumulating evidence has demonstrated that the PK2 protein in testicular tissue exists in only primary spermatocytes, and PK2 plays an essential role in inflammation by binding to PKR1, thus increasing the expression of PKR1. Interestingly, as a consequence of PK2 and PKR2 deficiencies, GnRH fails to be secreted, which results in dysfunctional sexual development and fertility in both male and female mice [12, 19–21]. To our knowledge, this is the first study to validate the changes in PK2 expression in the testes of mice with diabetes. Furthermore, our study focused on the presence of PKRs in mouse testes following STZ administration, which indicates that the expression of PK2 is expressed at low levels and in different patterns in the testes of diabetic mice. At the same time, PKR2 was noted to be overtly decreased and continuously expressed at a low level, while PKR1 was expressed at a lower level during the initial stage and then increased during the end stage of diabetes mellitus, which may be the main contributor to the expression of PK2 in response to inflammation and defective angiogenesis in diabetes. In addition, Met attenuated testicular injury by downregulating PKR1 activity, upregulating PK2/PKR2, and alleviating these pathologic alterations. The analysis indicates that the effect of Met is involved in regulating PK2 signalling pathways.

Cumulative evidence suggests that PK2/PKRs participate in myocardial survival, angiogenesis, and the haematopoietic system through the AKT and STAT3 signalling pathways [19, 22]. When culturing testicular tissue cells in vitro, the AKT signalling pathway regulates functional anchoring junctions, especially in Sertoli cells and spermatogenic cells [23]. Recent reports have indicated that higher AKT phosphorylation is tightly associated with testicular injury in STZ-induced diabetic mice; thus, we speculated that the AKT signal transduction pathway in testicular tissue could be used to investigate its effect on diabetes-induced testicular dysfunction. Our data suggest that the AKT/GSK3β signalling pathway continues to be inhibited during testicular injury in diabetes and that Met effectively reverses the diabetes-induced inactivation of AKT. It is conceivable that the uninterrupted high expression of PK2/PKR2 during Met treatment is beneficial for the activation of the AKT pathway.

Autophagy is a self-clearing process in eukaryotic cells. Normal autophagy can help maintain the balance of cell growth in organisms, especially to protect against testicular injury caused by hyperglycaemia and hypoxia [24]. However, abnormal autophagy is believed to be involved in the pathogenesis of many related diseases. Insufficient or excessive autophagy leads to the degeneration of germ cells. At the same time, it can degrade organelles, such as mitochondria and the endoplasmic reticulum, to destroy the stability of the testes, affecting their growth and development as well as their normal physiological functions [25]. Hyperglycaemia affects the mammalian target of rapamycin complex 1 (mTORC1) and leads to the inactivation of autophagy-related gene 4 (ATG4) by oxidation, ultimately leading to the lipidization of autophagy-related gene 8 (ATG8) and the formation of autophagy-related autophagosomes in the cell to induce autophagy [26]. The autophagy-related proteins Beclin-1, light chain 3B (LC3B), and ubiquitin-binding protein (p62/SQSTM1) are markers of autophagy activation in biological tissues. Beclin-1 and LC3B participate in the formation and elongation of autophagosomes, and p62, as a scaffold protein, binds ubiquitinated substrates and aids their aggregation and degradation by macroautophagy [27]. We noted suppressed autophagy, decreased Beclin-1 expression, a decreased LC3II-to-LC3I ratio, and increased p62 expression in diabetic mice, which corresponds to previous reports [28, 29]. Furthermore, we also found that Met treatment induces the enhancement of the autophagy level in testicular tissue.

Apoptosis, which is jointly regulated by the apoptosis-inducing gene Bax and the apoptosis-inhibiting gene Bcl-2, is considered a major factor in the possible mechanism of testicular injury induced by diabetes. An imbalance between Bax/Bcl-2 can activate the downstream caspase signalling pathway to induce apoptosis, which ultimately leads to spermatogenesis dysfunction [30]. Evidence suggests a link between autophagy and apoptosis pathways. Autophagy can remove excess cell components to inhibit apoptosis, and activation of the apoptosis-related protein caspase hinders the formation of autophagosomes [31]. Our study shows that the apoptosis of testicular tissue in diabetic mice is enhanced in parallel with increased Bax and decreased Bcl-2 and PCNA. When diabetic mice are treated with Met, the apoptosis of cells involved in the process of testicular injury is effectively inhibited. Therefore, our study supports a possible role for the PK2/PKR signalling cascade in the alteration of Met-elicited autophagic responses and the inhibition of apoptosis during diabetic toxicity.

In summary, our study strongly demonstrates that Met can regulate the PK2/PKR signalling pathway in testicular tissue, thereby eliciting AKT/GSK3β activity and regulating autophagic activity and apoptosis in testicular cells to protect the reproductive function of testicular tissue in mice. This study provides a new opportunity for the prevention and treatment of testicular reproductive injury, which is worthy of further clinical study.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors have no competing interests to declare.

Authors’ Contributions

YNL, ZY, DBK, and YZZ contributed to the development of this study. WY and WLZ contributed to the analysis and interpretation of the data. WY and WLZ were responsible for critically revising the manuscript for important intellectual content.

Acknowledgments

This work was supported by grants from the Family Planning Commission Project of Hubei Provincial Health Department (WJ2017M247); Xianning City of Science and Technology Fund Project (2018-52, 2017-47); Hubei Province Key Laboratory on Cardiovascular, Cerebrovascular, and Metabolic Disorders Fund Project (2019-20XZ03); and Research Innovation Team Project of Hubei University of Science and Technology (2018).

References

N. H. Cho, J. E. Shaw, S. Karuranga et al., “IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045,” Diabetes Research and Clinical Practice, vol. 138, pp. 271–281, 2018.
View at: Publisher Site | Google Scholar
S. Ghazi, W. Zohdy, Y. Elkhiat, and R. Shamloul, “Serum testosterone levels in diabetic men with and without erectile dysfunction,” Andrologia, vol. 44, no. 6, pp. 373–380, 2012.
View at: Publisher Site | Google Scholar
I. M. Agbaje, D. A. Rogers, C. M. McVicar et al., “Insulin dependant diabetes mellitus: implications for male reproductive function,” Human Reproduction, vol. 22, no. 7, pp. 1871–1877, 2007.
View at: Publisher Site | Google Scholar
M. Kanter, C. Aktas, and M. Erboga, “Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin-induced diabetic rat testis,” Food and Chemical Toxicology, vol. 50, no. 3-4, pp. 719–725, 2012.
View at: Publisher Site | Google Scholar
F. A. Masoudi, S. E. Inzucchi, Y. Wang, E. P. Havranek, J. M. Foody, and H. M. Krumholz, “Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study,” Circulation, vol. 111, no. 5, pp. 583–590, 2005.
View at: Publisher Site | Google Scholar
Y. Li, C. Ryu, M. Munie et al., “Association of metformin treatment with reduced severity of diabetic retinopathy in type 2 diabetic patients,” Journal Diabetes Research, vol. 2018, article 2801450, 8 pages, 2018.
View at: Publisher Site | Google Scholar
C. Mollay, C. Wechselberger, G. Mignogna et al., “Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats,” European Journal of Pharmacology, vol. 374, no. 2, pp. 189–196, 1999.
View at: Publisher Site | Google Scholar
L. Negri and N. Ferrara, “The prokineticins: neuromodulators and mediators of inflammation and myeloid cell-dependent angiogenesis,” Physiological Reviews, vol. 98, no. 2, pp. 1055–1082, 2018.
View at: Publisher Site | Google Scholar
F. Shojaei, X. Wu, C. Zhong et al., “Bv8 regulates myeloid-cell-dependent tumour angiogenesis,” Nature, vol. 450, no. 7171, pp. 825–831, 2007.
View at: Publisher Site | Google Scholar
E. Giannini, R. Lattanzi, A. Nicotra et al., “The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 34, pp. 14646–14651, 2009.
View at: Publisher Site | Google Scholar
S. Burroughs, W. F. Schwindinger, J. J. Venditti, T. Trautwein, A. Dalsania, and C. M. Klingerman, “Prokineticin-2 and ghrelin robustly influence the sexual and ingestive behaviors of female Syrian hamsters,” Hormones and Behavior, vol. 106, pp. 135–143, 2018.
View at: Publisher Site | Google Scholar
L. H. Tu, L. L. Yu, C. L. Xiong, and H. P. Zhang, “Potential role of prokineticin 2 in experimental varicocele-induced rat testes,” Urology, vol. 80, no. 4, pp. 952.e15–952.e19, 2012.
View at: Publisher Site | Google Scholar
S. Matsumoto, C. Yamazaki, K. H. Masumoto et al., “Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 11, pp. 4140–4145, 2006.
View at: Publisher Site | Google Scholar
W. Yu, W. Zha, S. Guo, H. Cheng, J. Wu, and C. Liu, “Flos Puerariae extract prevents myocardial apoptosis via attenuation oxidative stress in streptozotocin-induced diabetic mice,” PLoS One, vol. 9, no. 5, article e98044, 2014.
View at: Publisher Site | Google Scholar
G. J. Shi, J. Zheng, X. X. Han et al., “Lycium barbarum polysaccharide attenuates diabetic testicular dysfunction via inhibition of the PI3K/Akt pathway-mediated abnormal autophagy in male mice,” Cell and Tissue Research, vol. 374, no. 3, pp. 653–666, 2018.
View at: Publisher Site | Google Scholar
M. G. Alves, A. D. Martins, L. Rato, P. I. Moreira, S. Socorro, and P. F. Oliveira, “Molecular mechanisms beyond glucose transport in diabetes-related male infertility,” Biochimica et Biophysica Acta, vol. 1832, no. 5, pp. 626–635, 2013.
View at: Publisher Site | Google Scholar
K. Oishi, M. Barchi, A. C. Au, B. D. Gelb, and G. A. Diaz, “Male infertility due to germ cell apoptosis in mice lacking the thiamin carrier, Tht1. A new insight into the critical role of thiamin in spermatogenesis,” Developmental Biology, vol. 266, no. 2, pp. 299–309, 2004.
View at: Publisher Site | Google Scholar
J. Chen, C. Kuei, S. Sutton et al., “Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1,” Molecular Pharmacology, vol. 67, no. 6, pp. 2070–2076, 2005.
View at: Publisher Site | Google Scholar
H. Xin, R. Lu, H. Lee et al., “G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells,” The Journal of Biological Chemistry, vol. 288, no. 19, pp. 13842–13849, 2013.
View at: Publisher Site | Google Scholar
N. Pitteloud, C. Zhang, D. Pignatelli et al., “Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 44, pp. 17447–17452, 2007.
View at: Publisher Site | Google Scholar
A. A. Sinisi, R. Asci, G. Bellastella et al., “Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report,” Human Reproduction, vol. 23, no. 10, pp. 2380–2384, 2008.
View at: Publisher Site | Google Scholar
K. Urayama, C. Guilini, N. Messaddeq et al., “The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis,” The FASEB Journal, vol. 21, no. 11, pp. 2980–2993, 2007.
View at: Publisher Site | Google Scholar
M. K. Siu, C. H. Wong, W. M. Lee, and C. Y. Cheng, “Sertoli-germ cell anchoring junction dynamics in the testis are regulated by an interplay of lipid and protein kinases,” The Journal of Biological Chemistry, vol. 280, no. 26, pp. 25029–25047, 2005.
View at: Publisher Site | Google Scholar
S. Sato, S. Kataoka, A. Kimura, and Y. Mukai, “Azuki bean (Vigna angularis) extract reduces oxidative stress and stimulates autophagy in the kidneys of streptozotocin-induced early diabetic rats,” Canadian Journal of Physiology and Pharmacology, vol. 94, no. 12, pp. 1298–1303, 2016.
View at: Publisher Site | Google Scholar
Y. Wang, W. Zheng, X. Bian et al., “Zearalenone induces apoptosis and cytoprotective autophagy in primary Leydig cells,” Toxicology Letters, vol. 226, no. 2, pp. 182–191, 2014.
View at: Publisher Site | Google Scholar
Y. Xiao, H. Liu, J. Yu et al., “MAPK1/3 regulate hepatic lipid metabolism via ATG7-dependent autophagy,” Autophagy, vol. 12, no. 3, pp. 592-593, 2016.
View at: Publisher Site | Google Scholar
X. Zhou, W. Hao, H. Shi, Y. Hou, and Q. Xu, “Calcium homeostasis disruption - a bridge connecting cadmium-induced apoptosis, autophagy and tumorigenesis,” Oncology Research and Treatment, vol. 38, no. 6, pp. 311–315, 2015.
View at: Publisher Site | Google Scholar
Y. M. Song, Y. H. Lee, J. W. Kim et al., “Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway,” Autophagy, vol. 11, no. 1, pp. 46–59, 2015.
View at: Publisher Site | Google Scholar
A. C. T. Teng, T. Miyake, S. Yokoe et al., “Metformin increases degradation of phospholamban via autophagy in cardiomyocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 23, pp. 7165–7170, 2015.
View at: Publisher Site | Google Scholar
X. Jiang, Y. Bai, Z. Zhang, Y. Xin, and L. Cai, “Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function,” Toxicology and Applied Pharmacology, vol. 279, no. 2, pp. 198–210, 2014.
View at: Publisher Site | Google Scholar
J. Chang, W. Wang, H. Zhang, Y. Hu, M. Wang, and Z. Yin, “The dual role of autophagy in chondrocyte responses in the pathogenesis of articular cartilage degeneration in osteoarthritis,” International Journal of Molecular Medicine, vol. 32, no. 6, pp. 1311–1318, 2013.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2019 Yuning Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies